These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23545891)

  • 1. Identifying and addressing barriers to insulin acceptance and adherence in patients with type 2 diabetes mellitus.
    Petznick AM
    J Am Osteopath Assoc; 2013 Apr; 113(4 Suppl 2):S6-16. PubMed ID: 23545891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
    Rakel RE
    Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacist's role in maintaining adherence to insulin therapy in type 2 diabetes mellitus.
    Vivian EM
    Consult Pharm; 2007 Apr; 22(4):320-32. PubMed ID: 17658964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration.
    Abu Hassan H; Tohid H; Mohd Amin R; Long Bidin MB; Muthupalaniappen L; Omar K
    BMC Fam Pract; 2013 Oct; 14():164. PubMed ID: 24164794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007 Jun; 29(6 Pt 1):1236-53. PubMed ID: 18036387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empowering patients during insulin initiation: a real-world approach.
    LaSalle JR
    J Am Osteopath Assoc; 2010 Feb; 110(2):69-78. PubMed ID: 20160245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
    Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
    J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment.
    Guo XH; Ji LN; Lu JM; Liu J; Lou QQ; Liu J; Shen L; Zhang MX; Lv XF; Gu MJ
    J Diabetes; 2014 Jul; 6(4):290-7. PubMed ID: 24279284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing barriers to initiation of insulin in patients with type 2 diabetes.
    Peyrot M; Rubin RR; Khunti K
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S11-8. PubMed ID: 20394886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil.
    Eliaschewitz FG; de Paula MA; Pedrosa HC; Pires AC; Salles JEN; Tambascia MA; A Turatti LA
    Diabetes Metab Syndr; 2018; 12(1):39-44. PubMed ID: 28864058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin.
    Raccah D; Chou E; Colagiuri S; Gaàl Z; Lavalle F; Mkrtumyan A; Nikonova E; Tentolouris N; Vidal J; Davies M
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27606888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing Patient Acceptance and Adherence Toward Insulin.
    Riddle M; Peters A; Funnell M
    Postgrad Med; 2016 Oct; 128 Suppl 1():11-20. PubMed ID: 27109558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of patient education on KAP, medication adherence and therapeutic outcomes of metformin versus insulin therapy in patients with gestational diabetes: A Hospital based pilot study in South India.
    Krishnakumar S; Govindarajulu Y; Vishwanath U; Nagasubramanian VR; Palani T
    Diabetes Metab Syndr; 2020; 14(5):1379-1383. PubMed ID: 32755838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in medication adherence and self-management of diabetes with a clinical pharmacy program: a randomized controlled trial in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital.
    Cani CG; Lopes Lda S; Queiroz M; Nery M
    Clinics (Sao Paulo); 2015 Feb; 70(2):102-6. PubMed ID: 25789518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment.
    Fonseca VA; Haggar MA
    Nat Rev Endocrinol; 2014 May; 10(5):276-81. PubMed ID: 24535209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.
    Marrero DG
    Clin Cornerstone; 2007; 8(2):33-40; discussion 41-3. PubMed ID: 18357954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
    Vinik A
    Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the treatment of type 2 diabetes using current and future insulin technologies.
    Boyle ME
    Medsurg Nurs; 2008 Dec; 17(6):383-90. PubMed ID: 19248402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from Biphasic Human Insulin to Premix Insulin Analogs: A Review of the Evidence Regarding Quality of Life and Adherence to Medication in Type 2 Diabetes Mellitus.
    El Naggar N; Kalra S
    Adv Ther; 2017 Jan; 33(12):2091-2109. PubMed ID: 27739002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.